Updated NTM pulmonary disease estimates in U.S. Medicare beneficiaries revealed rising incidence, demographic disparities, and associated comorbidities.

in adult patients with nontuberculous mycobacterial (NTM) pulmonary disease. The therapy showed an improvement in at least 50 ...

USA-based Paratek Pharmaceuticals has released positive top-line data from a Phase IIb trial evaluating its oral antibiotic ...

Paratek Pharma announces positive top-line data from phase 2b study of oral omadacycline in NTM abscessus pulmonary disease: Boston Monday, November 11, 2024, 18:00 Hrs [IST] Para ...

Insmed sees growth with ARIKAYCE and upcoming Brensocatib approval. Find out why INSM stock is a strong pick with significant ...

In a study of 66 adult patients with nontuberculous mycobacteria pulmonary disease (NTM-PD) caused by mycobacterium abscessus ...

At Durban's King Dinuzulu Hospital, a TB patient with advanced lung disease awaits surgery for massive haemoptysis - severe ...

The mucus is a common symptom in chronic lung diseases such as COPD ( chronic bronchitis and emphysema), cystic fibrosis, bronchiectasis, NTM lung disease, or asthma. Besides ailments related to lungs ...

Mycobacterium avium complex (MAC) is group of organisms causing a bacterial infection that leads to lung disease. MAC is noncontagious and made up of nontuberculous mycobacteria (NTM), which are ...